SUPN icon

Supernus Pharmaceuticals (SUPN)

NASDAQ

$54.76

-$1.03 (

-1.84%

)

1D
5D
1M
6M
1Y
5Y
Market closed

SUPN: $54.76 / ₿ 0.0008 BTC / 83288 Sats

1D
5D
1M
6M
1Y
5Y

Key statistics

$55.78
$29.16 - $59.68
$3.15B
18.48
$56.59
$875,702.19
57.46M
$30.00 - $87.68
$53.18 - $56.59
Yes

What is Supernus Pharmaceuticals (SUPN)?

Supernus Pharmaceuticals Inc is a specialty pharmaceutical company. The company is engaged in developing and commercializing products for the treatment of central nervous system diseases, including neurological and psychiatric disorders. Its diverse neuroscience portfolio includes approved treatments for epilepsy, migraine, attention-deficit hyperactivity disorder (ADHD), hypomobility in Parkinson's Disease (PD), cervical dystonia, chronic sialorrhea, dyskinesia in PD patients receiving levodopa-based therapy, and drug-induced extrapyramidal reactions in adult patients. The company's products include Trokendi XR, Oxtellar XR, Qelbree, APOKYN, XADAGO, MYOBLOC, GOCOVRI, and Osmolex ER.

The Supernus Pharmaceuticals (SUPN) stock price has been falling

The Supernus Pharmaceuticals, Inc. Common Stock (SUPN) stock price today is $54.76, reflecting a -1.84% move since the market opened. The company’s market capitalization stands at $3.15B, with a daily trading volume of $875.70K shares. For investors tracking price trends, Supernus Pharmaceuticals, Inc. Common Stock stock has ranged between $53.18 and $56.59 today. The previous closing price was $55.78.

Get started with Supernus Pharmaceuticals (SUPN)

Ready to get started? Follow the steps below, or read our guide on how to buy Supernus Pharmaceuticals stock on Kraken starting from $10.

Create an account

Create an account

Open the Kraken app to confirm your eligibility and follow the steps for account verification.



Deposit funds

Deposit funds

Once your account has been verified and stock trading is unlocked, you can deposit funds into your account using your preferred payment method.

Buy

Buy SUPN

Search for SUPN in the Kraken app, enter the amount you want to invest, review the important details and tap Confirm to place an order to buy SUPN.

SUPN FAQs

SUPN is in the Healthcare sector. Sector is a broad classification that groups companies based on their business activities, industry focus or economic function.

SUPN is in the Drug Manufacturers - Specialty & Generic industry. Industry is a more specific classification within a sector, grouping companies that operate in a similar field and have closely related business models.

Over the past 52 weeks, Supernus Pharmaceuticals, Inc. Common Stock (SUPN) has traded between a low of $29.16 and a high of $59.68.

SUPN is in the Drug Manufacturers industry group. Industry group is a further subdivision within an industry, grouping companies with even more closely related business models and operations. This helps investors analyze stocks at a more detailed level than sector and industry classifications alone.

Want to invest in Supernus Pharmaceuticals? 
Get the Kraken app

Eligible US clients can now invest in over 11,000 stocks and ETFs - commission-free* - directly in the Kraken app. Download it and get started.

Fictional stock
USD icon
USD
SUPN icon
SUPN

Only available to USA clients through the Kraken app
or Kraken Pro.

Get the Kraken Pro app and buy Supernus Pharmaceuticals in minutes

Kraken App QR Code

Explore other stocks

Most active

Explore the most-traded stocks today

Top gainers

Browse today’s biggest stock market winners

Top losers

Compare the worst-performing stocks of 
the day

OTRKQ icon

OTRKQ

YOTAR icon

YOTAR

CRESW icon

Want to learn more about equities?

Check out our Kraken Learn Center guides

Currently available in the U.S. only; may not be available in all states. Brokerage services are provided by Kraken Securities LLC, member FINRA/SIPC. Please view the firm’s profile, registration and background of our registered reps on https://brokercheck.finra.org/. Digital asset services offered by Payward Interactive, not a member of FINRA/ SIPC and not FDIC insured. This is not an offer, solicitation, inducement or advice to buy or sell securities, or open a brokerage account in any jurisdiction where Kraken Securities is not registered. All trading involves risk, including loss of your investments. View full disclosures at: Equities Disclosures and Crypto Risk Disclosures.

*Other applicable fees may apply.